Taiho’s Oral, Mutation-Agnostic DMD Candidate Misses Phase III Endpoint

Japan-Only Trial

 
• By Lisa Takagi
  
DMD p3 in Japan
Japan Phase III miss for Taisho's DMD candidate but multiple others in development in country (Shutterstock)

More from Clinical Trials

More from Japan